OPN - Revisited

Journal of Clinical and Diagnostic Research

Volumn 9, Issue 6, 2015, Pages ZE10-ZE13

  Subramani, Vijayanirmala ^a   Thiyagarajan, Muthukumar ^a   Malathi, N ^a   Rajan, Sharada T ^a  

^a SRI RAMACHANDRA UNIVERSITY   (India)

Author keywords

Angiogenesis; Cell adhesion; Metastasis; Osteopontin

Indexed keywords

HERMES ANTIGEN; INTEGRIN; OSTEOPONTIN;

ANGIOGENESIS; APOPTOSIS; CELL ADHESION; CELL MIGRATION; CELL SURVIVAL; GENE STRUCTURE; HUMAN; INFLAMMATION; METASTASIS; NEOPLASM; PLEIOTROPY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; WOUND HEALING;

EID: 84930680408     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2015/12872.6111     Document Type: Review

References (45)

1. Gursoy G, Acar Y, Alagoz S, Ankara SB. Osteopontin: A multifunctional Molecule. J Med and Med Science. 2010;1(3):055-060.
2. Rodrigues LR, Teixeira JA, Schmitt FL, Paulsson M, Mansson HL. Metastasis in Breast cancer. Cancer Epidemiol Biomarkers Prev. 2007;16:1087-97.
3. Wang KX, Shi YF, Ron Y, Kazanecki CC, Denhardt DT. Plasma Osteopontin Modulates chronic Restraint stress Induced Thymus Atrophy by Regulating Stress Hormones: Inhibition by an Anti Osteopontin Monoclonal antibody. The Journal of Immunology. 2009;182:2485-91.
4. Fatherazi S, Matsa-Dunn D, Foster BL, Rutherford RB, Somerman MJ, Preland RB. Phosphate regulates osteopontin Gene transcription. J Dent Res. 2009;88(1);39-44.
5. Anborgh PH, Mutrie JC, Tuck AB, Chambers AF. Pre and post translational regulation of osteopontin in cancer. J Cell commun Signal. 2011;5:111-22.
6. Kumar GS. Orban’s Oral histology & Embryology. 13th Edition, Elsevier;2013. Ch.9: pp. 207-8.
7. Standal T, Borset M, Sundan A. Role of Osteopontin in Adhesion, Migration, cell Survival and Bone Remodeling. Exp Oncol. 2004;26(3):179-84.
8. Sodek J, Ganss B, McKee MD. Ostepontin. Crit Rev Oral Biol Med. 2000;11(3):279-303.
9. Sodek J, Da Silva APB, Zohar R. Osteopontin and Mucosal protection. J Dent Re. 2006;85(5):404-15.
10. Denhardt DT, Guo X. Osteopontin: a protein with diverse function. FASEB J. 1993;7:1475-82.
11. Rittling SR, Chambers AF. Role of osteopontin in tumour progression. British J Cancer. 2004;90:1877-81.
12. Junaid A, Moon MC, Harding GEJ, Zahradka P. Osteopontin Localizes to the nucleus of 293 cells and associates with p1-like kinase-1. Am J physiol cell Physiol. 2007;292(2):c919-26.
13. Scatena M, Almeida M, Chaisson ML, Fausto N, Nicosia RF, Giachelli CM. NF-KB mediates avh3 integrin-induced endothelial cell survival. J Cell Biol. 1998;141:1083-93.
14. Denhard DT, Noda M, O’Regan AW, Pavlin D, Berman JS. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodelling and cell survival. The Journal of clinical investigation. 2001;107(9):1055-61.
15. Brown LF, Sergiou AR, Berse B, Manseu EJ, et al. Osteopontin Expression and Distribution in Human Carcinomas. American Journal of Pathology. 1994;145(3):610-23.
16. Ue T, Yokozaki H, Kitadai Y, Yamamoto S, et al. Co-expression of osteopontin and cd44v9 in gastric cancer. Int J Cancer (Pred Oncol) 1998;79:127-32.
17. Devoll RE, Li W, Woods KV, Pinero GJ, et al. Osteopontin (OPN) distribution in premalignant and malignant lesions of oral epithelium and expression in cell lines derived from squamous cell carcinoma of the oral cavity. J Oral Pathol Med. 1999;28:97-101.
18. Agarwal D, Chen T, Irby R, Quackenbush J, et al. Osteopontin Identified as Lead Marker of Colon Cancer Progression, Using Pooled Sample Expression Profiling. Journal of the National Cancer Institute. 2002;94(7):513-21.
19. Rudland PS, Higgins AP, Tanani ME, Rudland SDS, et al. Prognostic Significance of the Metastasis-associated Protein Osteopontin in Human Breast Cancer. Cancer Research. 2002;62:3417-27.
20. Coppola D, Szabo M, Boulware D, Muraca P, et al. Correlation of Osteopontin Protein Expression and Pathological Stage across a Wide Variety of Tumour Histologies. Clinical Cancer Research. 2002;10:184-90.
21. Celetti A, Testa D, Staibano S, Merolla F, et al. Overexpression of the Cytokine Osteopontin Identifies Aggressive Laryngeal squamous cell carcinomas and enhances carcinoma Cell Proliferation and Invasiveness. Clin Cancer Res. 2005;11(22):8019-27.
22. Donati V, Boldrini L, Dell’Omodarme M, Maria C, et al. Osteopontin Expression and Prognostic Significance in Non Small Cell Lung Cancer. Clin Cancer Res. 2005;11(18):6459-65.
23. Kita Y, Natsugoe1 S, Okumura H, Matsumoto M, et al. Expression of Osteopontin in oaesophageal squamous cell carcinoma. British Journal of Cancer. 2006;95:634-38.
24. Matsuzaki H, Shima K, Muramatsu T, Ro Y, et al. Expression of Osteopontin in oaesophageal squamous cell carcinoma. J Oral Pathol Med. 2007;36(1):30-34.
25. Tigrani DY, Weydert JA. Immunohistochemistry Expression of osteopontin in Epitheliod Mesotheliomas and Reactive Mesothelial proliferations. Am J Clin pathol. 2007;27:580-84.
26. Chien CY, Su CY, Chuang HC, Fang FM, et al. Clinical Significance of osteopontin expression in T1 and T2 Tongue cancers. Head & neck. 2008;10:776-81.
27. Wu IC, Yang SF, Wu CC, Hsu WH, et al. Expression of Osteopontin Protein in Aesophageal Squamous Cell Carcinoma. J Intern Med Taiwan. 2010;21:419-26.
28. Zhang LL, Shao SL, Wu Y. The expression and significance of Osteopontin and B7H4 in epithelial ovarian neoplasm. Chinese Journal of Cancer. 2010;29(1):24-28.
29. Ogbureke KUE, Abdelsayed RA, Kushner H, BA LL, Fisher LW. Two members of the sibling family of proteins, dspp and bsp, may predict the transition of oral epithelial dysplasia to oral squamous cell carcinoma. Cancer. 2010;116(7):1709-17.
30. Han WH, Wei WX, Tangcan E. Osteopontin expression in nasopharyngeal carcinoma: Its relevance to the clinical stage of the disease. J Can Research and Therapeutics. 2011;7(2)138-42.
31. Conti J, Thomas G. The role of tumour stroma in colorectal cancer invasion and metastasis. Cancer. 2011;107(9):1055-61.
32. Allan AL, Geroge R, Vantyghem SA, Lee MW, et al. Role of the integrin-Binding protein Osteopontin in lymphatic metastasis of breast cancer. Am J pathology. 2006;169(1):233-46.
33. Choi S, Myers JN. Molecular Pathogenesis of Oral Squamous Cell Carcinoma: Implications for Therapy. J Dent Res. 2008;87(1):14-32.
34. Khuri FR, Shin DM, Glisson BS, Lippman SM, Hong WK. Treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck: current status and future directions. Semin Oncol. 2000;27:25-33.
35. Diez-perez R, Campo-trapero J, Anzo-Sanchez J. World Health Organization. Strengthening the prevention of oral cancer: the WHO perspective. Community Dent Oral Epidermiol. 2005;33:397-99.
36. Marsh D, Suchak K, Moutasim KA. Stromal features are predictive of disease morality in oral cancer patients. J Pathol. 2011;223:430-81.
37. Fedarko NS, Jain A, Karadag A, Van Eman MR, et al. Elevated Serum Bone Sialoprotein and Osteopontin in Colon, Breast, Prostate, and Lung Cancer Clinical Cancer Research. 2001;7:4060-66.
38. Kim JH, Skates SJ, Uede T, Wong KK, et al. Osteopontin as a Potential Diagnostic Biomarker for Ovarian cancer. JAMA. 2002;287:1671-79.
39. Katakura A, Kamiyama I, Takano N, Shibahara T, et al. Comparsion of salivary cytokine levels in oral cancer patients and Healthy subjects. Bull Tokyo Dent Cell. 2007;48(4):199-203.
40. Le QT, Sutphin PD, Raychaudhuri S, Yu SCT, et al. Identification of Osteopontin as a Prognostic Plasma Marker for Head and Neck Squamous Cell Carcinomas. Clinical Cancer Research. 2003;9:59-67.
41. Koopmann J, Fedarko NS, Jain A, Maitra A, et al. Evaluation of Osteopontin as Biomarker for Pancreatic Adenocarcinoma. Cancer Epidemiol Biomarkers Prev. 2004;13:487-91.
42. Bramwell VHC, Doig GS, Tuck AB, Wilson SM, et al. Serial Plasma Osteopontin Levels Have Prognostic Value in metastatic Breast cancer. Clin Cancer Res. 2006;12:3337-43.
43. Petrik D, Lavori PW, Cao H, Zhu Y, et al. Plasma Osteopontin Is an Independent Prognostic Marker for Head and Neck Cancers. Journal of Clinical Oncology. 2006;24:5291-97.
44. Cho HB, Hong SW, Oh YJ, Kim MA, et al. Clinical significance of osteopontin expression in cervical cancer. J Cancer Res Clin Oncol. 2008;134:909-17.
45. Zhou ZT, Wei BJ, Shi P Osteopontin expression in oral lichen planus. J Oral Pathol Med. 2008;37:94-98.